BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Insulet Reports First Quarter 2019 Revenue of $159.6 Million, an Increase of 29% Year-Over-Year

  Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced financial results for the three months ended March 31, 2019.

  May 2, 2019

   · 

  10 min read
• Business

  Xencor to Host First Quarter 2019 Financial Results Webcast and Conference Call on May 9, 2019

  It will release first quarter 2019 financial results after the market closes on Thursday, May 9, 2019.

  May 2, 2019

   · 

  1 min read
• Business

  Ligand Reports First Quarter 2019 Financial Results

  Conference Call Begins at 4:30 p.m. Eastern Time Today

  May 2, 2019

   · 

  21 min read
• Business

  Apollo Endosurgery, Inc. Reports First Quarter 2019 Results

  Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET

  May 2, 2019

   · 

  9 min read
• Business

  Bruker Reports First Quarter 2019 Financial Results

  Q1 2019 revenue growth of 6.9% year-over-year, organic revenue growth of 5.5%

  May 2, 2019

   · 

  17 min read
• Business

  ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2019

  Year-over-year revenue grows 12%, gross margin improves 100 basis points, operating profit up 15%

  May 2, 2019

   · 

  17 min read
• Business

  Castlight Health Announces First Quarter 2019 Results

  Today announced results for its first quarter ended March 31, 2019.

  May 2, 2019

   · 

  12 min read
• Drug Development

  AMAL Therapeutics enters clinical collaboration with Boehringer Ingelheim to evaluate ATP128 in combination with BI754091

  AMAL Therapeutics (AMAL), a Swiss biotech developing novel, peptide-based therapeutic cancer vaccines, today announces that it has entered into a collaborative agreement with Boehringer Ingelheim

  May 2, 2019

   · 

  2 min read
• Deals

  Natera Announces First Quarter 2019 Earnings Conference Call

  Natera, Inc. announced that it will release results for its first quarter ended March 31, 2019, after the market close on May 9, 2019.

  May 2, 2019

   · 

  1 min read
• Genetown

  Cryohub: Bringing A Revolutionary New Fat Loss Technology to Boston

  Annually, more than 45 million Americans set about on a weight loss journey.

  May 2, 2019

   · 

  2 min read